Marburg antigen screening
Rapid Marburg antigen screeningfor outbreak-response programs.
GoldN Easy to Use Marburg Rapid Antigen Test is a rapid antigen screening assay for public-health, outbreak-response, and institutional evaluation where timely Marburg virus disease screening is needed.
Not a U.S. consumer product. Not sold on areyougoldn.com.
- Marburg antigenScreening designed for Marburg virus disease response
- Fingerstick sampleSmall blood sample for rapid screening workflows
- Visual readoutQualitative antigen result with a control line
- Field-readyBuilt for outbreak-response and limited-infrastructure settings
Test workflow
Built for simple, decentralized screening.
The workflow prioritizes minimal training burden and clear visual interpretation for program deployment.
- 01
Collect the blood sample
Obtain the fingerstick blood sample per program protocol and instructions.
- 02
Run the assay
Apply sample and buffer to the test cassette according to instructions.
- 03
Wait for development
Allow the strip to develop the control and test line pattern.
- 04
Read the result
Interpret the visual qualitative result. Confirmatory clinical assessment remains available when symptoms persist.
Assay design
Marburg virus antigen screening for program deployment.
- Target
- Marburg virusAntigen screening framed for Marburg virus disease programs.
- Users
- Trained program staffHealthcare workers, NGOs, and authorized organizations.
- Setting
- Outbreak and fieldClinical, outbreak-response, and limited-infrastructure sites.
- Readout
- Visual qualitativeAntigen presence or absence with a control-line check.
- Limit
- Screening useA negative result does not rule out Marburg virus disease.
FAQ
Program questions in plain clinical language.
The assay is designed to screen for Marburg virus antigen as part of Marburg virus disease response and program evaluation workflows.
The test uses a fingerstick blood sample for rapid antigen screening workflows.
Healthcare workers, public health programs, NGOs, and authorized organizations conducting Marburg screening activities.
Clinical, outbreak-response, and field settings, including areas with limited laboratory infrastructure.
The test provides a visual result indicating the presence or absence of Marburg virus antigen. A control line confirms proper test function. Results are qualitative and intended for screening purposes.
No. A negative result does not definitively rule out Marburg virus disease. If symptoms persist, further clinical assessment and confirmatory testing are recommended.
Governments, NGOs, and distributors may request pricing and availability by contacting NOVODX through this website.
Ready for program discussions
Bring Marburg antigen screening into your program evaluation.
Governments, NGOs, and authorized organizations can request program information, evaluation supply, and procurement discussions.
Final clinical performance, labeling, and regulatory claims remain subject to validation and applicable regulatory review. A negative screening result does not rule out Marburg virus disease.